Research
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial
BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39098.583356.55 (Published 29 March 2007) Cite this as: BMJ 2007;334:674
Related articles
- Editorial Published: 29 March 2007; BMJ 334 doi:10.1136/bmj.39161.665579.BE
- Practice Published: 06 July 2006; BMJ 333 doi:10.1136/bmj.333.7558.83
- Research Published: 24 May 2011; BMJ 342 doi:10.1136/bmj.d3036
- Editor's Choice Published: 29 March 2007; BMJ 334 doi:10.1136/bmj.39169.480775.3A
- Research Published: 24 July 2019; BMJ 366 doi:10.1136/bmj.l4363
See more
- Sixty seconds on . . . 10 000 stepsBMJ March 08, 2024, 384 q598; DOI: https://doi.org/10.1136/bmj.q598
- Scarlett McNally: Enabling active travel can improve the UK’s healthBMJ March 06, 2024, 384 q522; DOI: https://doi.org/10.1136/bmj.q522
- Scarlett McNally: Boosting swimming for health and joyBMJ February 20, 2024, 384 q393; DOI: https://doi.org/10.1136/bmj.q393
- Variability in blood pressure could help predict heart attack and stroke risk, researchers sayBMJ February 09, 2024, 384 q363; DOI: https://doi.org/10.1136/bmj.q363
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
Cited by...
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)
- Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
- Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review
- Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
- Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism
- Deep vein thromboses in users of opioid drugs: incidence, prevalence, and risk factors
- Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials
- Duration of Anticoagulation: Applying the Guidelines and Beyond
- Duration of Anticoagulation Therapy for Venous Thromboembolism
- 6 or 3 months of anticoagulant therapy did not differ for treatment failure in patients with DVT, PE, or both
- How Long to Treat Venous Thromboembolism?
- Anticoagulation for venous thromboembolism
- Thrombophilia: Common Questions on Laboratory Assessment and Management